Positive Results of Bone Marrow Regeneration Trial, Mesoblast (ASX: MSB; ADR: MBLTY)
July 12th, 2010
No comments
MSB’s positive results from its bone marrow transplant clinical trial conducted at the University of Texas MD Anderson Cancer Center resulted in a formal meeting being scheduled with the US FDA to discuss a proposed Phase 3 clinical trial program. Read more…
